Global access Target health systems and NGOs in regions with limited breast cancer screening access, emphasizing Vara's AI-powered Mammography platform as a scalable, objective, and measurable screening tool that can democratize early detection worldwide.

Clinical collaboration Leverage partnerships with screening radiologists and medical centers in Germany and beyond to co-develop implementation models, ensuring workflow integration, radiologist acceptance, and clinically proven impact to accelerate deployment.

Operational efficiency Position Vara as a solution to reduce repetitive tasks and subjectivity in reading mammograms, highlighting potential cost savings, throughput gains, and improved consistency to appeal to hospital administration and procurement teams.

Cloud and data Emphasize cloud-native infrastructure and scalable tech stack (AWS, GCP, Terraform) to reassure security-conscious buyers about deployment speed, data governance, and interoperability with existing PACS and IT ecosystems.

Strategic funding angle In markets where public or private payers are encouraging early detection programs, pitch Vara as a value driver for screening initiatives, aligning with health policy trends and potential reimbursement pathways to support adoption.